C. Wegerski

发表

Carbon capture and sequestration: an exploratory inhalation toxicity assessment of amine-trapping solvents and their degradation products.

Eladio Knipping, Melanie Doyle-Eisele, Stephanie Shaw, 2014, Environmental science & technology.

Metabolism and disposition of 2-hydroxy-4-methoxybenzophenone, a sunscreen ingredient, in Harlan Sprague Dawley rats and B6C3F1/N mice; a species and route comparison

J. McDonald, B. McIntyre, M. Doyle-Eisele, 2020, Xenobiotica; the fate of foreign compounds in biological systems.

A serendipitous discovery of isomotuporin-containing sponge populations of Theonella swinhoei.

P. Crews, K. Tenney, C. Wegerski, 2007, Journal of natural products.

Abstract 2698: eFT226, a potent and selective inhibitor of eIF4A, is efficacious in preclinical models of lymphoma

P. A. Thompson, K. Webster, N. Young, 2019, Experimental and Molecular Therapeutics.

Structure-based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition.

P. A. Thompson, C. Stumpf, Qing Han, 2018, Journal of medicinal chemistry.

Strategic Diastereoselective C1 Functionalization in the Aza-Rocaglamide Scaffold toward Natural Product-Inspired eIF4A Inhibitors.

P. A. Thompson, P. Sprengeler, S. Reich, 2020, Organic letters.

Design of Development Candidate eFT226, a First in Class Inhibitor of Eukaryotic Initiation Factor 4A RNA Helicase.

P. A. Thompson, K. Webster, N. Young, 2020, Journal of medicinal chemistry.

eFT508, a Potent and Selective Mitogen-Activated Protein Kinase Interacting Kinase (MNK) 1 and 2 Inhibitor, Is Efficacious in Preclinical Models of Diffuse Large B-Cell Lymphoma (DLBCL)

P. A. Thompson, K. Webster, Katti A. Jessen, 2015 .

Abstract 596: eFT508, a potent and highly selective inhibitor of MNK1/2 regulates immune checkpoint and cytokine expression promoting anti-tumor immunity

P. A. Thompson, C. Stumpf, K. Webster, 2017 .

Abstract PR11: eFT508: An oral, potent and highly selective inhibitor of MNK1 and MNK2, promotes anti-tumor immunity as a monotherapy and in combination with immune checkpoint blockade

P. A. Thompson, C. Stumpf, K. Webster, 2017 .

Disposition and metabolism of 2′,2′”-Dithiobisbenzanilide in rodents following intravenous and oral administration and dermal application

J. McDonald, M. Doyle-Eisele, C. Garner, 2020, Toxicology reports.

Using a kinase screen to investigate the constituents of the sponge Stelletta clavosa obtained from diverse habitats.

P. Crews, C. Wegerski, D. France, 2004, Bioorganic & medicinal chemistry.

Comparative disposition of dimethylaminoethanol and choline in rats and mice following oral or intravenous administration.

J. McDonald, C. Garner, S. Waidyanatha, 2019, Toxicology and applied pharmacology.

Stereochemical challenges in characterizing nitrogenous spiro-axane sesquiterpenes from the Indo-Pacific sponges Amorphinopsis and Axinyssa

F. Valeriote, P. Crews, C. Wegerski, 2006 .

Targeting Oncogene mRNA Translation in B-Cell Malignancies with eFT226, a Potent and Selective Inhibitor of eIF4A

P. A. Thompson, K. Webster, N. Young, 2020, Molecular Cancer Therapeutics.

Preclinical Evaluation of eFT226, a Novel, Potent and Selective eIF4A Inhibitor with Anti-Tumor Activity in B-Cell Malignancies

P. A. Thompson, K. Webster, N. Young, 2017 .

Disposition of &bgr;‐N‐methylamino‐L‐alanine (L‐BMAA), a neurotoxin, in rodents following a single or repeated oral exposure

J. McDonald, S. Waidyanatha, C. Wegerski, 2018, Toxicology and applied pharmacology.